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Abstract.  Catecholamines were found to activate 
Na/H exchange in a concentration-dependent manner 
in primary cultures of vascular smooth muscle cells 
(VSMC). The potency order was found to be epineph- 
rine >  norepinephrine  >  isoproterenol.  The major 
pathway for catecholamine effects appeared to be via 
interaction with an alpha~ adrenergic  receptor.  In addi- 
tion,  it was found that alpha1 receptor-mediated Na/H 
exchange in VSMC was increased by angiotensin II 
and inhibited by 12-O-tetradecanoyl phorbol-D-acetate 
(TPA). 
Adrenergic receptors have been shown to be coupled 
to both adenylate cyclase and to inositol phosphate re- 
lease (Leeb-Lundberg, L.  M.  E,  S.  Cotecchia, J. W. 
Lomasney, J.  E  DeBernadis,  R. J.  Lefkowitz, and 
M.  G.  Caron,  1985, Proc. Natl.  Acad.  $ci. USA, 
82:5651-5655.).  It was found that catecholamines in- 
creased AMP levels in the potency order isoproterenol 
>  norepinephrine  >  epinephrine and the receptor in- 
volved was a beta adrenergic  receptor.  Since these 
findings did not parallel the results obtained for cate- 
cholamine stimulation of Na/H exchange, an increase 
in AMP levels was probably not the mechanism by 
which major pathway for catecholamine-stimulated 
Na/H exchange in VSMC (via the alpha]  receptor) was 
activated.  When the effects of catecholamines were 
measured on inositol phosphate release, the potency 
order for catecholamine stimulation  was epinephrine 
>  norepinephrine  >  isoproterenol,  and the receptor in- 
volved was an alpha~ adrenergic  receptor.  In addition, 
angiotensin II increased and TPA inhibited 
catecholamine-stimulated  inositol phosphate release. 
Since these findings paralleled the results obtained for 
catecholamine stimulation of Na/H exchange,  inositol 
phosphate release may be the mechanism by which the 
major pathway for catecholamine-stimulated  Na/H ex- 
change in VSMC (via the alphal  receptor) was acti- 
vated. 
V 
ASCULAR smooth muscle cell (VSMC) t proliferation 
is thought to be important  in physiological processes 
such as wound healing and in pathological  processes 
such as atheromatous  plaque formation  (18). Concerning  the 
latter, Ross and colleagues proposed that when the vessel en- 
dothelial  lining  is damaged,  circulating  blood platelets  ad- 
here to the exposed collagen.  Upon adherence to collagen, 
platelets become activated and secrete their granular  constit- 
uents.  Among  these  granular  constituents  is  the  peptide 
mitogen known as platelet-derived  growth factor. Although 
many laboratories have described the mitogenic  potency of 
platelet-derived  growth factor (19), its mechanism  of action 
has not been identified. 
Since Na/H exchange has been shown to be stimulated by 
a  wide variety of mitogenic  agents  in many  different  cell 
types (8,  9,  15,  16), we hypothesized that  platelet-derived 
growth factor might stimulate Na/H exchange in VSMC. In 
this regard,  it was found that platelet-derived  growth factor 
1.  Abbreviations  used  in  this  paper:  I*C-DMO,  [JaC]5,5-dimethyl-2-4- 
oxazolidine-dione; Epi, epinephrine; FBS, fetal bovine serum; lso, isopro- 
terenol; MEM, minimal essential medium; NE, norepinephrine; TPA, 12- 
O-tetradecanoyl phorbol-13-acetate; VSMC, vascular smooth muscle cells. 
activated amiloride-sensitive  Na influx in VSMC (14). An- 
other agent shown to be mitogenic for VSMC is angiotensin 
II (6). In addition,  Smith et al.  have demonstrated  that an- 
giotensin  II could activate Na/H exchange  in VSMC (20). 
Recently, my laboratory has shown that DNA synthesis and 
Na/H exchange in VSMC could be stimulated by biologically 
active phorbol esters such as 12-O-tetradecanoyl phorbol-13- 
acetate  (TPA) (13). These  studies  demonstrate  that  three 
different VSMC mitogens can also stimulate Na/H exchange 
in VSMC. Since Na/H exchange has been proposed to be im- 
portant in control of cell proliferation  (8, 9, 15, 16), it is im- 
portant to understand  how this transport system is regulated 
in VSMC. 
To study regulation  of Na/H exchange  in VSMC,  we fo- 
cused on the effects of catecholamines.  Catecholamines  were 
chosen because they too have been shown to stimulate DNA 
synthesis in VSMC (2) and have been postulated to be linked 
to atherosclerosis  (2). Furthermore, catecholamines  (such as 
epinephrine  [Epi],  norepinephrine  [NE],  or isoproterenol 
[Iso]) are known to exert their biological activities via inter- 
action with two types of membrane receptors (designated al- 
pha and beta). These receptor types have been identified by 
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rank potency order for agonist binding to the alpha receptor 
is Epi i> NE >  Iso; and the rank potency order for agonist 
binding to the beta receptor is Iso > Epi i> NE (7).  The two 
basic receptor types have been further subdivided using spe- 
cific antagonists. In this regard, alpha receptors have been 
categorized as alpha1, which predominate in smooth muscle 
and gland cells, and alpha2, which are proposed to exist on 
nerve terminals. Similarly, beta receptors have been classi- 
fied as betat, which are found in cardiac tissue and beta2, 
which are present in smooth muscle and gland tissue. 
Finally, adrenergic receptors have been shown to be linked 
to two second messenger systems: adenylate cyclase (26) and 
inositol phosphate release (10). Thus, due to their physiologi- 
cal relevance, the wide variety of available  receptor probes, 
and their linkage to second messengers, we chose to study 
catecholamine effects on Na/H exchange as a means of un- 
derstanding the regulation of the system. Two questions were 
addressed: (a) what are the characteristics of catecholamine- 
stimulated Na/H exchange in VSMC? and (b) by what mech- 
anism do catecholamines activate Na/H exchange in VSMC? 
Materials and Methods 
Materials 
Benzamil was provided by Dr. E. Cragoe of Merck, Sharp & Dohme Div., 
West Point, PA. Phentolamine was obtained from Ciba-Geigy Corp. (Ards- 
ley, NY). Prazosin was the gift of Pfizer Chemicals Div., Pfizer, Inc, (New 
York,  NY).  B-HT 920 was from Boehringer Ingleheim, Elmsford, NY. 
Rauwolscine was purchased from Atomergic Chemetals Corp., Plainview, 
NY.  Angiotensin II, Epi, Iso, NE, ouabain, phenylephrine, propranalol, 
and TPA were purchased from Sigma Chemical Co., St. Louis, MO. Dul- 
becco's  modified  Eagle's  medium  (DME),  minimal  essential  medium 
(MEM), and fetal bovine serum (FBS) were purchased from K.C. Biologi- 
cals  Inc.,  Lenexa,  KS.  [SH]Myoinositol  and  [~C]5,5-dimethyl-2-4-oxa- 
zolidine-dione  (~C-DMO)  were  purchased  from  Amersham  Corp., 
Arlington Heights, IL. 
Cell Culture 
VSMC were obtained from rat thoracic aorta by the explant method de- 
scribed by Ross (17). Female Sprague Dawley rats weighing 200-300 g were 
decapitated and the thoracic aorta removed. All subsequent procedures were 
performed under sterile conditions. After removal of fat and connective tis- 
sue, the aorta was opened, pinned in a wax-coated petri dish, and immersed 
in phenol red-free Hanks' salts. The intima/media layer was peeled away 
from the adventitia with forceps, and the pieces of intima media were rinsed 
several times with Hanks' salts. They were then minced into small pieces 
(,'~1 mm square) and placed in 35-ml Falcon "Primaria" flasks (Falcon Lab- 
wares, Oxnard, CA). The explants were allowed to partially dry onto the 
surface of the flask and were then fed with 5 ml DME + 20% FBS, 50 U/ml 
penicillin and streptomycin, and 500 I.tg/ml gentamycin sulfate.  The flasks 
were loosely stoppered and placed in a 37°C incubator. 
Smooth muscle cells grew out of some of the explants within 7-21  d. 
When the colonies became confluent the cells were detached by treatment 
with 0.01% trypsin and resuspended into a  T-75 Falcon flask containing 
10 ml DME +  10% FBS +  antibiotics (penicillin, streptomycin, and gen- 
tamycin). The medium was replaced after 24 h, and the cells were passaged 
when they reached confluence. Smooth muscle cell morphology was ver- 
ified by light and electron microscopy; cells were used between passages 
5-15. 
Net Na Influx 
Na influx measurements were carried out as described (14). Cells were re- 
moved from stock flasks  by trypsinization and subcultured onto 60-mm 
dishes. Cells were used 3-5 d after subculture while they were in the loga- 
rithmic phase of growth.  Before flux  measurements, cells were  serum 
deprived for 4 h at 37°C in an air atmosphere in amino acid-free Hepes- 
buffered MEM containing 0.1% FBS to reduce basal Na influx to that level 
observed in quiescent cells. After serum deprivation and with the respective 
treatments, Na influx was assayed in amino acid-free Hepes-buffered MEM 
in the presence of 2 mM ouabain, which is added to inhibit the active efflux 
of Na from the cells by the Na-K ATPase. Amino acid-free medium was 
used to prevent Na transport via Na/amino acid cotransport systems (i.e., 
"A system"). At a concentration of 2 mM, ouabaln inhibits Na-K ATPase 
activity immediately (24). Dishes were incubated at 37°C in a gyrotary bath 
at 100 rpm. Assay times ranged from 1-5 min. Na uptake was terminated 
by aspiration of the assay medium and washing of the dishes with ice-cold 
isotonic MgCI2. Cells were extracted with 0.2% SDS for fluorometric pro- 
tein determination (25) (described below) or with 5 % TCA for Na determi- 
nation.  Na  concentration  was  measured  by  atomic  absorption  spec- 
trophotometry. Initial net Na influx was taken as the linear phase of a plot 
of Na content (l~mol/g protein) vs. time. 
Intracellular ptt Measurements 
lntracellular pH was determined by measuring weak and distribution with 
14C-DMO. Cells were subcultured onto 60-ram dishes as described for Na 
transport  measurements.  Cells  were  serum-deprived for 4  h  in  amino 
acid-free Hepes-buffered MEM at 37°C  in an air atmosphere. For ~4C- 
DMO distribution the isotope was allowed to equilibrate for 5 min in amino 
acid-free Hepes-buffered MEM containing 50 I.tM "cold" DMO. The assay 
medium was then aspirated and  the dishes washed in  ice-cold isotonic 
MgCI2. The medium was then sampled for specific activity determination 
and the cells extracted with 0.2% SDS. An aliquot of the SDS extract was 
counted to determine t4C-DMO  distribution. Intracellular pH was calcu- 
lated from the following equation: 
pHi  =  pKi  +  log ~  (10  pH°-pK° +1)  -1, 
where pK for DMO is 6.1  (4). 
cAMP Assay 
For cAMP measurements, cells were subcultured onto six-well cluster plates 
(35 ram) at a density of 1 x  105 cells/well in DME +  10% FBS. 24 h after 
subculture each well was washed with Hepes-buffered MEM and the cells 
treated with appropriate agents. At the end of the specified incubation period 
the medium was rapidly removed and the cAMP was extracted with 200 I.tl 
of 0.1 N HCI. After 20 min the HCI solution was transferred to tubes and 
appropriate dilutions of the neutralized HCI extract were acetylated accord- 
ing to the method of Harper and Brooker (7), and cAMP was determined 
in triplicate by radioimmunoassay as described by Steiner et al. (22).  Pro- 
tein content was determined as described below. 
Inositol Phosphate Release Measurements 
Inositol phosphate release was measured according to a modification of the 
procedure of Berridge et al. (1). VSMC were subcultured onto 10-era plates 
and allowed to recover from subculture for 4 d. Ceils were then labeled with 
1 IK2i/ml [2-3H]myoinositol  for 48 h  in serum-free vitamin-free medium. 
To measure inositol phosphate release, [3H]inositol-labeled cells were 
washed twice with serum-free medium and then preincubated in serum-free 
medium in the presence of 10 mM LiCI,  which inhibits inositol-l-phos- 
phatase. Inositol phosphate release was then initiated by the addition of se- 
rum, catecholamines, angiotensin II, or TPA. The reaction was terminated 
after 10 min by the addition of ice-cold 10% TCA. The TCA was removed 
from the extract by washing it five times with an equal volume of diethyl 
ether.  The  lower aqueous  phase was neutralized by addition of sodium 
tetraborate (to 5 raM) and then transferred to a Dowex 1 formate column 
and washed twice with water.  The labeled inositol phosphates (inositol, 
glycerol phosphoinositol, inositol  1-phosphate,  inositol  1,4-bisphosphate, 
and  inositol  1,4,5-trisphosphate,  respectively)  were  sequentially  eluted 
with: (a) water; (b) 5 mM disodium tetraborate/60 mM sodium formate; 
(c)  100 mM formic acid/200 mM ammonium formate; (d) 100 mM formic 
acid/500 mM ammonium formate; and (e) 100 mM formic acid/1 M ammo- 
nium formate. Aliquots were drawn from each elution tube for the quantita- 
tion of 3H content by liquid scintillation counting. Identical dishes were 
used for fluorometric protein determination as described below. 
Fluorometric Protein Assay 
Cellular protein was determined using a fluorometric assay developed by 
Villereal and Cook (25).  Cells were extracted with 0.2% SDS, and the flu- 
orescence of the SDS extract was assessed at an excitation wavelength of 
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calculated from a  standard curve generated using bovine serum albumin. 
Calculation of  Data 
The  concentration of an agent using half-maximal stimulation (K,~)  was 
calculated from a double reciprocal plot. Variation in results is expressed 
as standard error of the  mean.  Tests for significance of differences were 
made by a  two-tailed Students t-test (unpaired means solution). 
Results 
Effect of Catecholamines on Na/H Exchange in VSMC 
When the concentration dependence  of Epi  stimulation  of 
Na/H exchange was measured,  it was found that Epi stimu- 
lated benzamil-sensitive Na influx in serum-deprived cells in 
a concentration-dependent manner. The K,~ was found to be 
1 IaaVl (Fig.  1).  In addition to Epi,  the effects of two other 
catecholamines  were tested,  i.e.,  NE and Iso.  NE and Iso 
were  also  found to stimulate  benzamil-sensitive  Na influx 
in  a  concentration-dependent  manner  in  serum-deprived 
VSMC. The K,~ for NE was found to be 2  ~tM (Fig.  1), and 
the K,/~ for Iso was found to be 5  ~tM  (Fig.  1). 
The Na/H exchange inhibitor benzamil (100 ~tM,  a maxi- 
mal  concentration)  was  found to  inhibit  all  of the  net  Na 
influx  in  response  to  a  maximal  concentration  of Epi  (10 
IxM), NE (10 ~tM), or Iso (10 lxM).  As previously reported 
by Owen (14) using VSMC and by Villereal (24) using human 
fibroblasts, benzamil had no effect on basal net Na influx. In 
addition to benzamil, the Na/H exchange inhibitor ethyliso- 
propylamiloride was also found to inhibit all of the catechol- 
amine-stimulated  Na influx,  without affecting basal Na in- 
flux (Owen, N., and E. Cragoe, unpublished observations). 
Finally, the three catecholamines were observed to cause 
a  Na-dependent  shift  in  intracellular  pH.  Intracellular  pH 
was  assessed  by  measuring  distribution  of the  weak  acid 
~4C-DMO.  It  was  found that  the  basal  pH  of 7.1  was  in- 
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Figure 1.  Na/H exchange  in VSMC: effect of Epi,  NE,  or Iso. 
VSMC were cultured and subcultured  as described in Materials and 
Methods.  Cells  were serum-deprived for 4 h in amino acid-free 
Hepes-buffered  MEM containing 0.1% FBS. Na influx was assayed 
in amino acid-free Hepes-buffered  MEM that contained  varying 
concentrations of Epi, NE, or Iso in the presence of 1 mM ouabain 
+  100 ~M benzamil.  Data are expressed  as benzamil-sensitive  Na 
influx (total Na influx  -  Na influx in the presence of benzamil). 
Values represent  mean -I- SEM from four quadruplicate  determina- 
tions. 
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Figure 2.  Na/H exchange  influx  in  VSMC: effect of adrenergic 
agonists and antagonists.  VSMC were cultured and subcultured  as 
described in Materials  and Methods.  Cells were serum-deprived 
for 4 h in amino acid-free Hepes-buffered  MEM containing 0.1% 
FBS. Na influx was then assayed in amino acid-free Hepes-buffered 
MEM  that contained  the  indicated  additions  in the presence of 
1 mM ouabain +  100 IxM benzamil. (A) Concentrations used were 
10 I.tM Epi, 10 I.tM NE,  10 laM Iso, 10 laM phentolamine,  and 10 
I.tM propranolol. Values represent mean + SEM from four quadru- 
plicate determinations.  (B) Concentrations used were 10 gM phen- 
ylephrine (Phenyl.), 10 gM Epi, 10 ~tM NE, and 10 laM B-HT 920. 
Values represent  mean -1- SEM from five quadruplicate  determina- 
tions. (C) Concentrations used were 10 txM NE, 100 nM prazosin, 
10 I.tM phentolamine  (Phent.) and 100 nM rauwolscine.  Values rep- 
resent  mean  +  SEM from five quadruplicate  determinations. 
creased to 7.4 in the presence of 10 IxM Epi. When Na was 
removed from the extracellular milieu (and replaced by cho- 
line),  the pH did not increase upon treatment with  10 IxM 
Epi.  The data reported in Fig.  1 demonstrate that catechol- 
amines stimulate Na/H exchange in VSMC in the potency or- 
der Epi  >  NE >  Iso. 
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on Na/H Exchange in VSMC 
The data reported in Fig.  1 suggested that the potency order 
for these three catecholamines was Epi >  Ne >  Iso.  This 
potency order mimicks that expected for an alpha-type re- 
ceptor.  To support the contention  that the catecholamines 
were interacting with an alpha receptor to stimulate Na/H ex- 
change, the effects of two adrenergic antagonists were mea- 
sured.  As shown in Fig. 2 A, both Epi- and NE-stimulated 
Na/H exchange (each at 10 p.M) were inhibited by the alpha 
receptor antagonist, phentolamine (10 ~tM),  but not by the 
beta antagonist,  propranalol (10 I~M).  This confirmed that 
the catecholamines Epi and NE were acting through an alpha 
receptor to stimulate Na/H exchange. The opposite was ob- 
served for Iso-stimulated Na/H exchange.  Thus,  Iso-stim- 
ulated  (10 IxM) Na/H exchange was not affected by the al- 
pha antagonist, phentolamine (10 ~tM),  but was completely 
blocked by the beta antagonist, propranolol (10 ~tM). These 
results confirmed that Iso was acting through a beta receptor 
to stimulate Na/H exchange.  Given the  small effect of Iso 
(only  slightly above basal) and  the high concentration  re- 
quired to elicit this effect, it was apparent that the major path- 
way for catecholamine-stimulated Na/H exchange was via 
the alpha receptor. 
Two types of alpha receptors have been identified;  these 
are designated alpha, and alpha2.  To determine which type 
of alpha receptor was mediating the Epi or NE effects on 
Na/H exchange in VSMC, we used specific agonists. Thus, 
we tested the effects of the alpha, agonist, phenylephrine (10 
I~M), and the alpha2  agonist, B-HT 920 (10 IxM) on Na/H 
exchange  in  VSMC.  As  shown  in  Fig.  2  B,  the  alpha, 
agonist,  phenylephrine,  was  quite  effective in  stimulating 
Na/H exchange,  while the alpha2  agonist,  B-HT 920,  was 
virtually without effect. These results indicated that the Epi- 
or NE-stimulated Na/H exchange was mediated through an 
alpha,  receptor. 
Further support that the effects of Epi or NE were medi- 
ated through  an alpha,  receptor was provided through the 
use  of  specific  alpha,  and  alpha2  antagonists.  Thus,  the 
alpha, antagonist, prazosin (100 nM), totally abolished NE- 
stimulated  (10  llM)  Na/H  exchange,  while  the  alpha2  an- 
tagonist,  rauwolscine (100 nM),  was without effect (Fig.  2 
C).  Similar effects were obtained using Epi.  These studies 
demonstrated  that  the  major  pathway  for  catecholamine- 
stimulated  Na/H  exchange  in  VSMC  is  mediated  by  an 
alpha,  adrenergic receptor. 
Effect of  Angiotensin H or TPA on 
Catecholamine-stimulated Na/H Exchange in VSMC 
To  further  characterize  the  effects  of catecholamines  on 
Na/H exchange in VSMC, we sought to determine the effect 
of Epi or NE on Na/H exchange when added in combination 
with other known activators of this transport system (i.e., 
growth factors such as angiotensin II [20] or phorbol esters 
such as TPA [13]). We focused on alpha, receptor-mediated 
effects because this was clearly the major pathway for cat- 
echolamine-stimulated  Na/H  exchange  in  VSMC.  When 
serum-deprived VSMC were challenged with maximal con- 
centrations of angiotensin II (100 nM) in the presence of ei- 
ther  Epi  (10  lxM)  or  NE  (10  llM),  Na/H  exchange  was 
markedly increased over the levels seen with the catechol- 
amines alone (Fig. 3 A). The next step was to determine the 
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Figure 3. Na/H exchange in VSMC: effect of catecholamines and 
angiotensin II and TPA. VSMC were cultured and subcultured as 
described  in Materials and Methods.  Cells were serum-deprived 
for 4 h in amino acid-free Hepes-buffered MEM containing 0.1% 
FBS.  (A) Na influx was assayed in amino  acid-free Hepes-buf- 
fered MEM in the presence of 1 mM ouabain  +  100 llM benza- 
mil  and the  indicated additions.  Concentrations  used were  10% 
FBS, 10 ktM Epi,  10 ktM NE, and 100 nM angiotensin II (AT H). 
Values represent mean +  SEM from six quadruplicate determina- 
tions.  (B)  Cells  were  then  preincubated  for  15  min  in  amino 
acid-free Hepes-buffered MEM that contained 0.01% drug vehicle 
(control, FBS, Epi, NE) or 0.16 ~tM TPA. Na influx was assayed 
in identical medium in the presence of 1 mM ouabain  -t- t00 ~tM 
benzamil with the indicated additions.  Concentrations  used were 
10% FBS, 10 ~tM Epi, 10 ~tM NE, and 0.16 ~tM TPA. Values repre- 
sent mean  ___  SEM from four quadruplicate determinations. 
effect of TPA on alphm receptor-mediated Na/H exchange. 
As shown in Fig.  3 B,  TPA (0.16 IxM) inhibited both Epi- 
stimulated  (10  ~tM) and  NE-stimulated (10  IxM) Na/H ex- 
change. These findings demonstrated that angiotensin II in- 
creases alpha, receptor-mediated Na/H exchange in VSMC. 
They also show that TPA inhibits alpha,  receptor-mediated 
Na/H exchange in VSMC. 
Effect of Catecholamines on cAMP Levels in VSMC 
After  characterizing  catecholamine  effects  on  Na/H  ex- 
change  in  VSMC  with  respect to  potency order,  receptor 
type, and effect of angiotensin II and TPA, the second major 
The Journal of Cell Biology, Volume  103, 1986  2056 ._',2 
o 
C, 
-6 
zo 
0 
A 
300 
200 
1oo 
0 
[]  Phentolamine 
~Propranolol 
_TL_ iiii~iiii 
iiiiiiiiii 
T 
300 r  B 
200 
100 
(  Epi  )  (  NE  )  (  Iso  ) 
C 
T 
NE  AT II  )'  TPA  ) 
+ NE  + NE 
Figure 4. AMP levels in VSMC: effect of catecholamines. VSMC 
were cultured and subcultured as described in Materials and Meth- 
ods. Cells were then treated with indicated agents and cAMP mea- 
sured as described in Materials and Methods. (A) The following 
concentrations  were used: 10 I~M Epi, 10 IxM NE, 10 IxM Iso, 10 ~tM 
phentolamine, and 10 ~tM propranalol. Data are expressed as per- 
cent control where control is basal cAMP level. Values represent 
mean + SEM from four triplicate determinations. (B) The follow- 
ing concentrations were used:  10 ~tM NE,  100 nM angiotensin II 
(AT H), and 0.16 IxM TPA. Data are expressed as percent control 
where control is basal cAMP level. Values represent mean ± SEM 
from six triplicate determinations. 
goal of our studies was to identify the mechanism by which 
catecholamines  activate  Na/H  exchange.  To  identify  the 
mechanism  by  which  catecholamines  activate  Na/H  ex- 
change, we measured catecholamine effects on the two sec- 
ond messenger systems known to be linked to adrenergic 
receptors, that is cAMP (26) and inositol phosphate release 
(10). 
cAMP was measured by radioimmunoassay (22) with the 
acetylation modification (7). As shown in Fig. 4 A, each of 
the catecholamines (10 ~M) stimulated cAMP levels signifi- 
cantly above control, and the potency order was found to be 
Iso > NE > Epi. This order is clearly different from that ob- 
served for stimulation of Na/H exchange (i.e., Epi >  NE > 
Iso). 
To assess  the receptor type involved, cells were treated 
with the alpha antagonist, phentolamine (10 ~M) and with 
the beta antagonist, propranolol (10 ~M). As shown in Fig. 
4 A, phentolamine had no effect  on catecholamine-stimulated 
(at 10 ~tM) cAMP levels, while propranolol completely in- 
hibited the cAMP increase. This suggests that the receptor 
involved in catecholamine-stimulated cAMP increases is the 
beta adrenergic receptor. This is clearly different from the 
alpha receptor involvement proposed for effects on Na/H ex- 
change. 
To further rule out a  role for cAMP in alpha,  receptor- 
mediated Na/H exchange, we tested the effect of angiotensin 
II or TPA on NE-stimulated cAMP levels. As shown in Fig. 
4 B, neither angiotensin II (100 nM) nor TPA (0.16 IxM) had 
any  effect on  NE-stimulated  (10  ~tM) cAMP  levels.  The 
finding  that  NE-stimulated  Na/H  exchange could be  sig- 
nificantly increased by angiotensin II or markedly inhibited 
by TPA, while NE-stimulated cAMP levels were unchanged 
(in addition  to the potency order and  the  involvement of 
the beta receptor described above, argued strongly against 
cAMP playing a  role in alpha,  mediated Na/H exchange. 
However, while cAMP clearly does not play a role in Epi- 
or NE-stimulated Na/H exchange, it may still be involved in 
the  slight  stimulation  of Na/H  exchange measured in  re- 
sponse to the beta agonist Iso. 
Effect of Catecholamines  on Inasitol Phosphate 
Release in VSMC 
Another  second  messenger  system  recently shown  to  be 
linked to adrenergic receptors is inositol phosphate release 
(10). Concerning this finding, we questioned whether cate- 
cholamine-stimulated Na/H exchange in VSMC was medi- 
ated through inositol phosphate release. Inositol phosphate 
release was measured in the presence of LiCI according to 
the method of Berridge (1) and is expressed as the sum of 
inositol  phosphate,  inositol biphosphate,  and  inositol tri- 
phosphate. As shown in Fig. 5 A, both Epi (10 lxM) and NE 
(10 tIM) stimulated inositol phosphate release significantly 
above control levels, whereas Iso did not. This potency order 
Epi >  NE >  Iso parallels that observed for stimulation of 
Na/H exchange. 
The receptor involvement was evaluated by measuring the 
effects of the alpha antagonist, phentolamine, and the beta 
antagonist, propranolol. As shown in Fig. 5 A, the effects of 
Epi (10 ~tM) and NE (10 IxM) were inhibited by the alpha 
blocker, phentolamine (10 ~tM), but not by the beta blocker, 
propranolol (10 ~tM). This suggests that the receptor type in- 
volved in mediating inositol phosphate release is the alpha 
receptor. This is identical to the findings for Epi and NE 
effects on Na/H exchange. These observations led to the sug- 
gestion that catecholamine stimulation of inositol phosphate 
release was mediated through an alpha adrenergic receptor. 
To clarify the type of alpha receptor involved in stimula- 
tion of inositol phosphate release, we again used the specific 
alpha1 agonist, phenylephrine, and the specific alpha2 ago- 
nist, B-HT 920. As shown in Fig. 5 B, phenylephrine (10 ~tM) 
significantly stimulated inositol phosphate release above ba- 
sal, while B-HT 920 (10 IxM) did not. This observation sug- 
gested that catecholamine-stimulated inositol phosphate re- 
lease was mediated through an alpha1  receptor. 
Further proof  that catecholamine-stimulated inositol phos- 
phate release was mediated through an alpha~ receptor was 
provided through the use of specific antagonists. As shown 
in  Fig.  5  C,  the  specific alphal  antagonist,  prazosin  (100 
nM), reduced NE-stimulated (10 ~tM) inositol phosphate re- 
lease to basal  levels,  while the specific alpha2  antagonist, 
rauwolscine (100 nM),  had no effect on NE-stimulated (10 
IxM) inositol phosphate release. 
Finally, we looked at the effect of angiotensin II and TPA 
on catecholamine-stimulated inositol phosphate release. As 
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Figure 5. Inositol phosphate release in VSMC: effect of catecholamines.  VSMC were cultured and subcultured as described in Materials 
and Methods.  Cells were labeled with [3H]inositol for 48 h in vitamin-free MEM containing 0.1% FBS. Inositol phosphate  release was 
stimulated with the indicated additions in the presence of 10 mM LiCI, and terminated after 10 min by the addition of 10 % TCA. (A) Concen- 
trations used were  10 ~tM Epi, 10 IxM NE,  10 ~tM Iso,  10 txM phentolamine, and 10 ~tM propranolol. Data are expressed as percent of 
control, where control is basal inositol phosphate release.  Values represent mean +  SEM from three determinations.  (B) Concentrations 
used were 10 lxM phenylephrine (phenyl.),  10 ~tM NE, 10 p.M Epi, and 10 laM B-HT 920. Data are expressed as percent of control, where 
control is basal inositol phosphate  release.  Values represent mean +  SEM from five determinations.  (C) Concentrations used were  10 
I~M NE, 100 nM prazosin, 10 IxM phentolamine (Phent.), and 100 nM rauwolscine.  Data are expressed as percent control where control 
is basal inositol phosphate release.  Values represent mean +  SEM from four determinations.  (D) Concentrations used were  10 IxM NE, 
100 nM angiotensin  II (ATH), and 0.16 I.tM TPA. Data are expressed as percent control where control is basal inositol phosphate release. 
Values represent mean +  SEM from six determinations. 
shown in Fig.  5 D,  angiotensin II (100 nM) also increased 
NE-stimulated (10 IxM) inositol phosphate release, and TPA 
(0.16  I~M) inhibited NE-stimulated  (10  ~tM) inositol phos- 
phate  release.  The finding that the potency order,  receptor 
type, and effects of angiotensin II and TPA were identical for 
the major pathway of catecholamine stimulation of Na/H ex- 
change and inositol phosphate release led us to conclude that 
the  major  pathway  of catecholamine-stimulated  Na/H  ex- 
change in VSMC  may be mediated through  inositol phos- 
phate  release. 
Discussion 
Previous studies have shown that DNA synthesis in VSMC 
can  be  stimulated  by peptide  growth  factors  (14, 19,  20), 
phorbol  esters  (13),  and  catecholamines  (2).  In  addition, 
both growth factors (14, 19) and phorbol esters (13) have been 
shown to also stimulate Na/H exchange.  Concerning these 
results, it has been proposed that VSMC in common with a 
wide variety  of other cells (8,  9,  15,  16) have  activation  of 
Na/H exchange as a step in the stimulus-transfer  pathway for 
DNA synthesis. In the present study, regulation of Na/H ex- 
change was investigated  by studying the effect of catechol- 
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suits, three catecholamines, Epi, NE, and Iso, were found to 
stimulate  Na/H  exchange  (benzamil-sensitive  net  Na  in- 
flux) in a concentration-dependent manner.  The K,h values 
were 1 glVl (Epi), 2 lxM (NE), and 5 ltM (Iso) which were 
in the appropriate range for binding to a specific membrane 
receptor. These results are the first evidence to suggest that 
catecholamines can stimulate Na/H exchange in VSMC. 
The major pathway  for catecholamine-stimulated Na/H 
exchange in  VSMC  is  via  an  alpha~ adrenergic receptor. 
Evidence to support this contention is provided by the ob- 
served potency order for the three agonists  on  Na/H  ex- 
change, i.e., Epi > NE > Iso. Additional support is provided 
by the finding that catecholamine-stimulated Na/H exchange 
was  significantly blocked by the alpha antagonist phentol- 
amine but not by the beta antagonist propranalol.  Finally, 
only  alpha~ agonists  were  found  to  stimulate  Na/H  ex- 
change  (alpha2  agonists  were  ineffective) and only alphat 
antagonists  were found to block NE-stimulated Na/H ex- 
change. 
Previous studies by Owen (14) and by Whiteley et al. (27) 
have examined the relationship between growth factors and 
the phorbol ester, TPA, in activating Na/H exchange. These 
experiments  suggested  that  while  TPA  alone  stimulated 
Na/H exchange, when TPA was  added together with epi- 
dermal growth factor it caused inhibition of epidermal growth 
factor-stimulated Na/H exchange. The present study probed 
the effect of both the growth factor, angiotensin II, and the 
phorbol ester, TPA, on catecholamine-stimulated Na/H ex- 
change. VSMC provide a unique model system in which to 
evaluate these interactions.  In this  regard,  many cultured 
cells appear to respond to growth factors and phorbol esters 
but few cultured cells have adrenergic receptors. 
Angiotensin  II  was  found  to  increase  alpha~ receptor 
mediated Na/H exchange. These results provide the first evi- 
dence that angiotensin II and catecholamines can have addi- 
tive effects on Na/H exchange in VSMC. Furthermore, TPA 
was  found  to  inhibit  alphat  receptor-mediated Na/H  ex- 
change in VSMC.  These results provide the first evidence 
that  TPA  can  inhibit  catecholamine-stimulated  Na/H  ex- 
change in VSMC. 
When the effects of catecholamines on cAMP levels were 
measured, it was found that the potency order, receptor in- 
volvement, and effects of angiotensin II and TPA were not 
in agreement with the results reported for catecholamine- 
stimulated Na/H exchange. This result was not unexpected 
since catecholamine-stimulated effects on cAMP are usually 
mediated through a beta receptor (26).  The lack of agree- 
ment between catecholamine effects on cAMP and on Na/H 
exchange were in marked contrast to the effects of catechol- 
amines on inositol phosphate release. In the latter case, the 
potency order, receptor involvement, and effects of angioten- 
sin  II and  TPA were  identical  to the  results  reported for 
catecholamine-stimulated Na/H exchange. This is the first 
report of catecholamine stimulation of inositol phosphate re- 
lease in VSMC, although others have made a similar obser- 
vation using vas deferens smooth muscle cells (10). In addi- 
tion,  these data are  the  first to demonstrate that NE can 
enhance angiotensin II-stimulated inositol phosphate release 
in VSMC (although others have measured the effect of an- 
giotensin II [5,  11, 21]).  Finally our work confirms and ex- 
tends reports which have suggested that TPA may modulate 
the activity of other agents (e.g., NE [8], angiotensin II [5], 
or carbachol [12, 23]) by inhibiting their ability to stimulate 
inositol phosphate release. 
On the basis of the studies measuring cAMP and inositol 
phosphate release, we propose that NE or Epi interact with 
an alpha~ receptor to cause inositol phosphate release which 
somehow,  possibly  via  inositol triphosphate-mediated Ca 
mobilization (11, 21), activates Na/H exchange. Both Smith 
et al.  (21) and Nabika et al.  (11) have provided evidence to 
suggest that inositol triphosphate can mobilize intracellular 
Ca in VSMC. It is important to note that Iso was also found 
to slightly stimulate Na/H exchange. Based on the present 
data, it seems that Iso interacts with a beta receptor to cause 
an increase in cAMP levels which somehow stimulates Na/H 
exchange.  Evidence that cAMP may be able to  stimulate 
Na/H  exchange in  VSMC  is  provided by our previously 
reported finding that the permeable cAMP analogue 8-Br- 
cAMP can mimick the effects of Iso  in stimulating  Na/H 
exchange (3).  However, it should be noted that given the 
magnitude of the effects, it appears that the putative cAMP- 
mediated pathway is a minor pathway and may not be physio- 
logically important. 
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